How routine use of a treat to target approach in PsA might impact on clinical decision making

How routine use of a treat to target approach in PsA might impact on clinical decision making

In recent years there has been increasing research focusing on the assessment of disease activity in psoriatic arthritis (PsA). PsA has been recognised as a potentially destructive and disabling arthritis and many observational studies have supported a link between inflammation and subsequent joint...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Coates, L
Natura:	Journal article
Lingua:	English
Pubblicazione:	Oxford University Press 2017

Documenti analoghi

Treat-to-target in PsA: methods and necessity
di: Dures, E, et al.
Pubblicazione: (2020)

What should be the primary target of ‘treat to target’ in PsA?
di: Coates, L, et al.
Pubblicazione: (2018)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
di: McGagh, D, et al.
Pubblicazione: (2020)

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
di: Coates, LC, et al.
Pubblicazione: (2021)

Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves et al.
di: Van Mens, L, et al.
Pubblicazione: (2019)

Ethical issues in a TwiCs study in early PsA
di: Coates, L, et al.
Pubblicazione: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
di: Coates, L, et al.
Pubblicazione: (2016)

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
di: Coates, LC, et al.
Pubblicazione: (2022)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
di: Helliwell, PS, et al.
Pubblicazione: (2022)

Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases
di: Coates, L, et al.
Pubblicazione: (2017)

Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
di: Coates, LC, et al.
Pubblicazione: (2021)

Comparing the visual analogue scale (VAS) and the numerical rating scale (NRS) in patient reported outcomes in PsA
di: Ye, W, et al.
Pubblicazione: (2020)

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
di: Mease, P, et al.
Pubblicazione: (2018)

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design
di: Rombach, I, et al.
Pubblicazione: (2021)

Sex-specific challenges in patients with psoriatic arthritis (PsA): preliminary results from a systematic literature review (SLR)
di: Coates, LC, et al.
Pubblicazione: (2021)

Screening/referral strategies for the early recognition of psoriatic arthritis (PsA) among patients with psoriasis: results of a GRAPPA survey
di: Song, K, et al.
Pubblicazione: (2023)

How might magnetic secular variation impact avian philopatry?
di: Wynn, J, et al.
Pubblicazione: (2022)

A Theory of How the Brain Might Work
di: Poggio, Tomaso
Pubblicazione: (2004)

Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe
di: Ogdie, A, et al.
Pubblicazione: (2022)

How bulk nanobubbles might survive
di: Tan, Beng Hau, et al.
Pubblicazione: (2020)

Eligibility for PTH therapy: How common might it be?
di: Moinuddin, M, et al.
Pubblicazione: (2007)

PSA is dead, long live PSA.
di: Vickers, A, et al.
Pubblicazione: (2012)

Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS
di: Gossec, L, et al.
Pubblicazione: (2024)

How a single personal revelation might not be a source of knowledge
di: Mawson, T
Pubblicazione: (2003)

Social marketing: how might this contribute to tackling obesity?
di: Rayner, M
Pubblicazione: (2007)

Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
di: Avery, K, et al.
Pubblicazione: (2008)

Kite might
di: Xiong, Wei
Pubblicazione: (2017)

Kite might
di: Tay, Yinxue
Pubblicazione: (2017)

Kite might
di: Nursyazana Jamil
Pubblicazione: (2017)

Kite might
di: Teo, Fiona Jia Xin
Pubblicazione: (2017)

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study
di: Daugla, D, et al.
Pubblicazione: (2013)

Might makes right: war-related payments in Bosnia and Herzegovina
di: Hronešová, J
Pubblicazione: (2016)

Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study
di: Coates, LC, et al.
Pubblicazione: (2023)

Making decisions : how to develop the skills that make for good decisions /
di: 215320 Juniper, Dean
Pubblicazione: (1998)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
di: Sävblom, C, et al.
Pubblicazione: (2005)

Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year
di: Merola, JF, et al.
Pubblicazione: (2020)

The Impact of a Target on Newsvendor Decisions
di: Chen, Lucy Gongtao, et al.
Pubblicazione: (2015)

The ECG in clinical decision-making /
di: 232641 Davey, Patrick
Pubblicazione: (2004)

How quickly might we forget the lessons of Covid-19?
di: Dorling, D
Pubblicazione: (2020)

Clinical, genetic and omics-based biomarkers that might support the identification of the development of psoriatic arthritis in individuals with psoriasis – a narrative review of the literature
di: Grohmann, T, et al.
Pubblicazione: (2024)